Get Live Data

The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

  2. Share Prices
  3. Bioventix Share Price
  4. Bioventix Share News
  5. UK earnings, trading statements calendar - next 7 days

Pin to quick picksBioventix Share News (BVXP)

Bioventix Information

Share Price Information for Bioventix (BVXP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,350.00
Bid: 4,300.00
Ask: 4,400.00
Change: 0.00 (0.00%)
Spread: 100.00 (2.326%)
Open: 4,350.00
High: 4,390.00
Low: 4,350.00
Prev. Close: 4,350.00
BVXP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK earnings, trading statements calendar - next 7 days

Mon, 17th Oct 2022 16:05

Tuesday 18 October 
888 Holdings PLCTrading Statement
Aptamer Group PLCFull Year Results
Arbuthnot Banking Group PLCTrading Statement
Baillie Gifford Japan Trust PLCFull Year Results
Bellway PLCFull Year Results
BP Marsh & Partners PLCHalf Year Results
essensys PLCFull Year Results
FD Technologies PLCHalf Year Results
Integrafin Holdings PLCTrading Statement
Ninety One PLC and LtdHalf Year Results
Quilter PLCTrading Statement
Revolution Bars Group PLCFull Year Results
Sosandar PLCTrading Statement
Wise PLCTrading Statement
Wednesday 19 October 
Antofagasta PLCQ3 Results
ASOS PLCFull Year Results
BHP Group Ltd Trading Statement
Hargreaves Lansdown PLCTrading Statement
Just Eat Takeaway.com NVTrading Statement
Liontrust Asset Management PLCTrading Statement
Man Group PLCTrading Statement
Moneysupermarket.com Group PLCTrading Statement
Network International Holdings PLCTrading Statement
Petropavlovsk PLCTrading Statement
Provident Financial PLCTrading Statement
Rathbones Group PLCQ3 Results
Spectris PLCQ3 Results
Quilter PLCTrading Statement
Thursday 20 October 
AJ Bell PLCTrading Statement
Bunzl PLCQ3 Results
Centamin PLCQ3 Results
Dechra Pharmaceuticals PLCTrading Statement
Dunelm Group PLCTrading Statement
GB Group PLCTrading Statement
International Personal Finance PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Luceco PLCTrading Statement
Nanoco Group PLCFull Year Results
National Express Group PLCTrading Statement
Relx PLCTrading Statement
RPS Group PLCTrading Statement
Schroder AsiaPacific Fund PLCQ3 Results
Schroder British Opportunities TrustTrading Statement
Schroders PLCTrading Statement
Segro PLCTrading Statement
SigmaRoc PLCTrading Statement
St James's Place PLCQ3 Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
XPS Pensions Group PLCTrading Statement
Friday 21 October 
Deliveroo PLCTrading Statement
InterContinental Hotels Group PLCTrading Statement
London Stock Exchange Group PLCTrading Statement
Record PLCTrading Statement
SIG PLCTrading Statement
Wickes Group PLCTrading Statement
Monday 24 October 
Bioventix PLCFull Year Results
Dr Martens PLCHalf Year Results
Pearson PLCQ3 Results
Schroder BSC Social Impact Trust PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
29 Mar 2022 17:05

TRADING UPDATES: Solid 2021 for Ten Entertainment, Central Asia Metals

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
28 Mar 2022 11:48

Bioventix hikes interim dividend after revenue falls

(Sharecast News) - Monoclonal antibody developer and supplier Bioventix reported an 8% fall in revenue in its first half on Monday, to £4.7m.

Read more
2 Dec 2021 16:04

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
19 Oct 2021 06:54

IN BRIEF: Bioventix lifts payout as revenue rises, but profit slips

IN BRIEF: Bioventix lifts payout as revenue rises, but profit slips

Read more
30 Mar 2021 06:58

IN BRIEF: Bioventix reports first-half fall in profit, raises dividend

IN BRIEF: Bioventix reports first-half fall in profit, raises dividend

Read more
29 Mar 2021 08:58

Bioventix revenue rises in tougher first half

(Sharecast News) - Diagnostic antibody developer Bioventix reported a 1.3% improvement in revenue in its first half on Monday, to £5.2m.

Read more
3 Dec 2020 16:13

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
19 Oct 2020 14:08

IN BRIEF: Bioventix Hikes Dividend Payout As Annual Earnings Rise

IN BRIEF: Bioventix Hikes Dividend Payout As Annual Earnings Rise

Read more
1 Jul 2020 18:18

UK EXECUTIVE CHANGE SUMMARY: New CFOs At Ideagen And Bioventix

UK EXECUTIVE CHANGE SUMMARY: New CFOs At Ideagen And Bioventix

Read more
1 Jul 2020 09:40

Bioventix appoints Bruce Hiscox as chief financial officer

(Sharecast News) - Antibodies developer Bioventix named Bruce Hiscock would join the group its new chief financial officer on Wednesday.

Read more
31 Mar 2020 18:59

CORRECT: Bioventix Reports "Strong" Interims, Increases Dividend

CORRECT: Bioventix Reports "Strong" Interims, Increases Dividend

Read more
30 Mar 2020 14:19

Bioventix Reports "Strong" Interim Performance, Increases Dividend

Bioventix Reports "Strong" Interim Performance, Increases Dividend

Read more
28 Oct 2019 18:50

DIRECTOR DEALINGS: Bioventix Non-Exec Chair Sells GBP78,000 In Shares

DIRECTOR DEALINGS: Bioventix Non-Exec Chair Sells GBP78,000 In Shares

Read more
21 Oct 2019 11:33

Bioventix full-year revenue and profits improve

(Sharecast News) - Bioventix, which specialises in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, reported a 6% improvement in revenue for the year on Monday, to £9.3m.

Read more
29 Mar 2019 08:31

Vitamin D antibodies drive first-half growth at Bioventix

(Sharecast News) - Monoclonal antibodies developer and supplier Bioventix reported a 24% improvement in its normalised revenue in its half-year report on Friday, to £4.4m.

Read more
123

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.